Normal view MARC view ISBD view

Nanoparticle drug delivery systems for cancer treatment [electronic resource] / edited by Hala Gali-Muhtasib, Racha Chouaib.

Contributor(s): Gali-Muhtasib, Hala [editor.] | Chouaib, Racha [editor.].
Material type: materialTypeLabelBookPublisher: Singapore : Jenny Stanford Publishing, 2019Description: 1 online resource (342 p.).ISBN: 9781000681413; 1000681416; 9780429341250; 0429341253; 9781000680874; 1000680878; 9781000681147; 1000681149.Subject(s): Cancer -- Chemotherapy | Drug delivery systems | Nanomedicine | MEDICAL / Biotechnology | MEDICAL / Oncology | SCIENCE / BiotechnologyDDC classification: 616.994061 Online resources: Taylor & Francis | OCLC metadata license agreement Summary: In recent years, nanoparticles--bionanomaterials with specific physicochemical properties--have gained a great deal of scientific interest owing to their unique structure. Nanoparticle-based drugs are now widely regarded as a safer, more precise, and more effective mode of cancer therapy, considering their ability to enhance drug bioavailability, improve site-specific drug delivery, and protect nontarget tissues from toxic therapeutic drugs. This book compiles and details cutting-edge research in nanomedicine from an interdisciplinary team of international cancer researchers who are currently revolutionizing drug delivery techniques through the development of nanomedicines and nanotheranostics. Edited by Hala Gali-Muhtasib and Racha Chouaib, two prominent cancer researchers, this book will appeal to anyone involved in nanotechnology, cancer therapy, or drug delivery research.
    average rating: 0.0 (0 votes)
No physical items for this record

Description based upon print version of record.

In recent years, nanoparticles--bionanomaterials with specific physicochemical properties--have gained a great deal of scientific interest owing to their unique structure. Nanoparticle-based drugs are now widely regarded as a safer, more precise, and more effective mode of cancer therapy, considering their ability to enhance drug bioavailability, improve site-specific drug delivery, and protect nontarget tissues from toxic therapeutic drugs. This book compiles and details cutting-edge research in nanomedicine from an interdisciplinary team of international cancer researchers who are currently revolutionizing drug delivery techniques through the development of nanomedicines and nanotheranostics. Edited by Hala Gali-Muhtasib and Racha Chouaib, two prominent cancer researchers, this book will appeal to anyone involved in nanotechnology, cancer therapy, or drug delivery research.

OCLC-licensed vendor bibliographic record.

There are no comments for this item.

Log in to your account to post a comment.